Wave Life Sciences Ltd. Revenue 2015–2025
Wave Life Sciences Ltd. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Wave Life Sciences Ltd. revenue for the quarter ending March 31, 2026 was 38.2 M, a 316.85% increase year-over-year.
- Wave Life Sciences Ltd. revenue for the twelve months ending March 31, 2026 was 75.8 M, a 21.67% decrease year-over-year.
- Wave Life Sciences Ltd. annual revenue for 2025 was 42.7 M, a 60.55% decrease from 2024.
- Wave Life Sciences Ltd. annual revenue for 2024 was 108.3 M, a 4.42% decrease from 2023.
- Wave Life Sciences Ltd. annual revenue for 2023 was 113.3 M, a 3005.10% increase from 2022.
- Wave Life Sciences Ltd. annual revenue for 2022 was 3.6 M.
Wave Life Sciences Ltd. (WVE) — Frequently Asked Questions
Wave Life Sciences Ltd. (WVE) is a publicly traded US company. It has a market capitalization of $955M. In fiscal 2025 it reported revenue of $43M and net income of -$204M. Explore WVE's stock price, financial statements, earnings history, margins and key ratios below.
What is Wave Life Sciences Ltd.'s market cap?
Wave Life Sciences Ltd. (WVE) has a market capitalization of $955M.
What is the WVE stock price?
WVE trades at $5.66 (-2.08% on the day).
How much revenue does Wave Life Sciences Ltd. make?
Wave Life Sciences Ltd. reported revenue of $43M in fiscal 2025.
Is WVE profitable?
In fiscal 2025, Wave Life Sciences Ltd. reported net income of -$204M.